ASCENDIS PHARMA A/S - ADR (ASND)

US04351P1012 - ADR

135.9  -1.03 (-0.75%)

After market: 135.9 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
7.78M
11.94%
51.17M
557.71%
266.718M
421.24%
440.73M
65.24%
EBITDA
YoY % growth
-436.39M
-35.88%
-543.86M
-24.63%
-428.796M
21.16%
-261.766M
38.95%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-451.79M
-36.65%
-561.81M
-24.35%
-447.707M
20.31%
-254.193M
43.22%
Operating Margin
-5,807.07%-1,097.93%-167.86%-57.68%
EPS
YoY % growth
-7.01
14.93%
-10.40
-48.36%
-8.56
17.69%
-4.60
46.21%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.53
22.61%
Revenue
Q2Q % growth
81.081M
141.38%
EBITDA
Q2Q % growth
-76.985MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-83.613M
41.81%
N/AN/AN/AN/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
-1.54
58.38%
-2.070.5325.51%
Q3 2023
Q2Q % growth
-2.88
4.95%
-2.43-0.45-18.71%
Q2 2023
Q2Q % growth
-2.16
-47.95%
-2.640.4818.26%
Q1 2023
Q2Q % growth
-1.98
10.41%
-2.710.7327.04%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
137.702M
501.32%
64.385M73.317M113.87%
Q3 2023
Q2Q % growth
48.034M
214.15%
49.077M-1.043M-2.13%
Q2 2023
Q2Q % growth
47.39M
669.32%
38.097M9.293M24.39%
Q1 2023
Q2Q % growth
33.59M
391.80%
21.956M11.634M52.99%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.66% 12.53% -2.55% 44.32%
Revenue-0.02% 2.23% 0.87% 13.15%